Vidofludimus
CAS: 717824-30-1
Ref. 3D-FV102840
10mg | A consultar | ||
25mg | A consultar | ||
50mg | A consultar | ||
100mg | A consultar | ||
250mg | A consultar |
Información del producto
- SC12267
- 1-Cyclopentene-1-carboxylic acid, 2-[[(3-fluoro-3′-methoxy[1,1′-biphenyl]-4-yl)amino]carbonyl]-
- 2-((3-Fluoro-3′-methoxy-[1,1′-biphenyl]-4-yl)carbamoyl)cyclopent-1-enecarboxylic acid
- 2-[[(3-Fluoro-3′-methoxy[1,1′-biphenyl]-4-yl)amino]carbonyl]-1-cyclopentene-1-carboxylic acid
Vidofludimus is a cytotoxic drug that has been shown to have potent antiproliferative activity. It binds to the mitochondrial membrane potential, inhibiting the production of ATP and inducing apoptosis in cells. Vidofludimus has also been shown to be effective against autoimmune diseases, such as primary sclerosing cholangitis (PSC) and inflammatory bowel disease (IBD). Vidofludimus inhibits the production of cytokines by inhibiting nuclear factor kappa-B (NF-κB), which is an important mediator in the immune response. Vidofludimus has been shown to inhibit the synthesis of nucleotides, which may contribute to its efficacy in treating kidney fibrosis. Vidofludimus is a chemical inhibitor that blocks protein synthesis through inhibition of polysomes in cells.
Propiedades químicas
Consulta técnica sobre: 3D-FV102840 Vidofludimus
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.